2009
Prospective Evaluation of Fetuses With Autoimmune-Associated Congenital Heart Block Followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study
Friedman DM, Kim MY, Copel JA, Llanos C, Davis C, Buyon JP. Prospective Evaluation of Fetuses With Autoimmune-Associated Congenital Heart Block Followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study. The American Journal Of Cardiology 2009, 103: 1102-1106. PMID: 19361597, PMCID: PMC2730772, DOI: 10.1016/j.amjcard.2008.12.027.Peer-Reviewed Original ResearchConceptsThird-degree blockSecond-degree blockCongenital heart blockFirst-degree blockDEX groupHeart blockAutoimmune-Associated Congenital Heart BlockEfficacy of dexamethasoneSteroid side effectsNormal sinus rhythmMedian ventricular ratesCardiac dysfunctionGestational ageVentricular rateNonrandomized studyProspective evaluationSinus rhythmGrowth restrictionPR intervalPacemaker useRare caseTherapeutic benefitSide effectsBirth ageDexamethasone
1991
Perinatal outcome of fetal complete atrioventricular block: A multicenter experience
Schmidt K, Ulmer H, Silverman N, Kleinman C, Copel J. Perinatal outcome of fetal complete atrioventricular block: A multicenter experience. Journal Of The American College Of Cardiology 1991, 17: 1360-1366. PMID: 2016455, DOI: 10.1016/s0735-1097(10)80148-2.Peer-Reviewed Original ResearchConceptsComplete atrioventricular blockBeats/minStructural heart defectsAtrial isomerismAtrioventricular blockVentricular rateAV blockAtrial rateHeart defectsFetal complete atrioventricular blockDiscordant AV connectionsLeft atrial isomerismConnective tissue diseaseNormal cardiac anatomySecond-degree blockComplete AV blockComplex structural heart defectsSlow atrial rateAntinuclear antibodiesPerinatal outcomesAV connectionsMulticenter experienceClinical courseNeonatal deathTissue disease